2023
DOI: 10.1016/j.bbcan.2022.188841
|View full text |Cite
|
Sign up to set email alerts
|

Lenvatinib plus immune checkpoint inhibitors or locoregional therapy in unresectable hepatocellular carcinoma: Lessons learned and moving forwards

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 86 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?